NASDAQ: XENT       Intersect Ent Inc
Last Price Today's Change   Day's Range   Trading Volume
24.45   -0.48 (1.93%)  24.36 - 25.39  343,400


Avg Volume (4 weeks):651,533
4 Weeks Range:22.22 - 26.24
4 Weeks Price Volatility (%):
52 Weeks Range:14.61 - 35.87
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Intersect ENT Inc is a drug device company that develops products for patients with ear, nose, and throat conditions. The firm’s key commercial products are the Propel brand of steroid-releasing implants, which are used in patients undergoing surgery for chronic sinusitis. These implants are placed into the ethmoid sinuses after surgery and are designed to expand and hold open the surgically enlarged sinus while releasing an anti-inflammatory steroid. After roughly 30 days, the implant is fully absorbed into the body. Intersect ENT generates the vast majority of its revenue in the United States.

  Be the first to like this.


3414  4674  636  186 

Top 10 Active Counters
 NIO 4.67+0.30 
 TTNP 0.334+0.084 
 SPY 331.95+1.03 
 SNCA 1.60+0.35 
 EEM 46.23+0.26 
 AVP 5.60-0.05 
 AMD 50.93+1.16 
 CHK 0.661-0.029 
 BAC 34.71-0.01 
 GE 11.81-0.03 
Partners & Brokers